UHL Products

  • S. No.
    Brand Name
    Packaging
    Composition
  • 1.
    Voglimark GM2 Tablet
    10x1x10
    Voglibose 0.2mg + Glimepiride 2mg + Metformin 500mg (SR)
  • 2.
    Voglimark-M SR 500 Tablet
    10x1x10
    Voglibose 0.2mg + Metformin 500mg (SR)
  • 3.
    Voglimark-0.3 Tablet
    10x1x10
    Voglibose 0.3mg (MD)

Mechanism of Action: Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective.
Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin..

Indications:
  • Type 2 diabetes.

Dosage: